ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Allorecognition"

  • 2019 American Transplant Congress

    The Impact of Biological Behavior of Allograft Infiltrating Lymphocytes during Early Phase

    Y. Ganchiku, R. Goto, R. Igarashi, R. Kanazawa, K. Shibuya, Y. Fukasaku, N. Kawamura, M. Zaistu, M. Watanabe, M. Fukai, A. Taketomi

    Gastroenterological Surgery I, Hokkaido University, Sapporo, Japan

    *Purpose: The graft infiltrating lymphocytes (GILs) build an immunological microenvironment locally. Reportedly the GILs within 72hrs posttransplantation do not attack allograft, but may prevent from…
  • 2019 American Transplant Congress

    IL-1β and IL-6 Facilitate T Cell Reconstitution in Heart Allograft Recipients Treated with Anti-Thymocyte Globulin

    S. Hasgur, R. Fan, A. Valujskikh

    Inflammation and Immunity, Cleveland Clinic, Cleveland, OH

    *Purpose: Antibody-mediated lymphocyte depletion is used in solid organ and stem cell transplantation. However, T cell reconstitution after lymphoablation may lead to acute rejection and…
  • 2019 American Transplant Congress

    Withaferin A Shifts Circulating Lymphocytes toward Protective T Cell Subsets and Prolongs Islet Allograft Survival in a Mouse Transplant Model

    K. Kumano1, M. Kanak2, C. Darden3, S. Vasu1, Y. Liu4, M. C. Lawrence1, B. Naziruddin4

    1Baylor Scott and White Research Institute, Dallas, TX, 2Department of Surgery, Virginia Commonwealth University, Richmond, VA, 3Institute of Biomedical Studies, Baylor University, Waco, TX, 4Baylor Simmons Transplant Institute, Dallas, TX

    *Purpose: : Immunosuppression protocols improve the efficacy of allogeneic islet transplantation. However, decline in islet graft function and toxicities imposed by current immunosuppressant drugs remain…
  • 2019 American Transplant Congress

    Torque Teno Virus is a Prognostic Biomarker for Acute Biopsy-Proven Alloreactivity in Kidney Transplants

    K. Doberer

    Dpt. of Internal Medicine III, Div. of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria

    *Purpose: Drug-induced immunosuppression in kidney transplantation is crucial to prevent allograft rejection, but increases risk for infectious, cardiovascular and malignant disease. Tailoring of immunosuppressive drug…
  • 2019 American Transplant Congress

    Blockade of C3aR1 Signaling Suppresses Alloreactive CD8+ T Cell Immunity and Prolongs Murine Cardiac Allograft Survival

    J. Horwitz, D. Mathern, P. Heeger

    Icahn School of Medicine at Mount Sinai, NY, NY

    *Purpose: Activation, differentiation and expansion of alloreactive CD8+ T cells, the dominant effectors that mediate murine heart allograft rejection, requires allorecognition, costimulation, and cytokine-initiated signals.…
  • 2019 American Transplant Congress

    Donor-Recipient HLA Mismatched Peptides Calculated by PIRCHE Algorithm Associate with De Novo Donor-Specific Cellular and Humoral Alloreactivity and Predicts Inferior Graft Outcome

    M. Meneghini1, E. Crespo2, M. Niemann3, A. Torija2, E. Melilli4, M. Jarque2, N. Montero4, J. Cruzado1, J. Grinyo1, O. Bestard1

    1Kidney Transplantation Unit, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain, 2Experimental Nephrology Laboratory, IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain, 3PIRCHE AG, Berlin, Germany, 4Kidney Transplantation Unit, Bellvitge University Hospital, L'Hospitalet de Llobregat. Barcelona, Spain

    *Purpose: PIRCHE-II algorithm predicts mismatched donor-derived HLA peptides number presented on recipient HLAclass-II molecules to recipient T-cells (indirect pathway of allorecognition) and has been associated…
  • 2019 American Transplant Congress

    Role of Innate Allorecognition Pathways in Mouse Renal Allograft Rejection

    D. Zhao1, H. Dai1, K. Abou-Daya1, A. Williams1, M. Oberbarnscheidt1, X. Li2, F. Lakkis1

    1Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, 2Houston Methodist Hospital Immunobiology & Transplant Science Center, Houston, TX

    *Purpose: Allograft rejection is initiated by host immune system distinguishing between self and allogeneic non-self (allorecognition). Paired immunoglobulin-like receptor (PIR) and CD47 are molecules expressed…
  • 2019 American Transplant Congress

    Transplantation Alone Induces Myeloid-Derived Suppressor Cells Which Can Suppress T Cell Responses

    Y. Lee, T. Zhang, J. S. Bromberg, J. R. Scalea

    University of Maryland, Baltimore, MD

    *Purpose: Myeloid-derived suppressor cells (MDSC) are a naturally occurring, heterogeneous population of highly immunosuppressive CD11b+GR-1+ cells that expand in response to inflammatory conditions. MDSCs develop…
  • 2019 American Transplant Congress

    Computational Assessment of T-cell and B-cell Allorecognition to Predict Donor HLA Immunogenicity

    H. C. Copley1, M. Elango1, V. Kosmoliaptsis2

    1Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospital, Cambridge, United Kingdom, 2University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospital & NIHR Blood and Transplant Research Unit in Organ Donation and Transplantation at the University of Cambridge, Cambridge, UK., Cambridge, United Kingdom

    *Purpose: Donor-specific alloantibody (DSA) development after solid-organ transplantation is a major cause of graft loss, and limits future transplant options. We have previously shown that…
  • 2019 American Transplant Congress

    Evaluating Allo-Specific CD57+ T Cells during Memory and Proliferative Responses

    A. Lucander, H. Xu, A. Kirk

    Department of Surgery, Duke University, Durham, NC

    *Purpose: We have previously identified subsets of CD57+ T cells that are resistant to B7 costimulation blockade (CoB) in kidney transplant recipients. The objective of…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 16
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences